Magazine Article | September 1, 2021

What's It Like Being A First-Time Biopharma CEO?

Source: Life Science Leader

By Rob Wright, Chief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL

Since the CEO position comes with such high expectations and stress, we thought it would be interesting to speak with three first-time CEOs to hear their tales of the good, the bad, and the ugly.

In this edited transcript of our June 2021 executive virtual roundtable (EVR), perspectives are provided by Roger Crystal, CEO, Opiant Pharmaceuticals; Frank Lee, CEO, Forma Therapeutics; and Ivana Magovcˇevic´-Liebisch, Ph.D., JD, CEO, Vigil Neuroscience.

If you like what you read but have not yet watched/listened to the video/audio of this EVR, be sure to check it out, because not all of it could be squeezed into this print version.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Life Science Leader